Fatal pulmonary embolism in hospitalised medical patients
- PMID: 9306945
- PMCID: PMC500077
- DOI: 10.1136/jcp.50.7.609
Fatal pulmonary embolism in hospitalised medical patients
Abstract
This study aimed to determine the frequency of fatal pulmonary emboli in hospitalised medical patients by a retrospective necropsy review and prospective non-interventional patient follow up study. The main outcome measure, necropsy proven fatal pulmonary embolism, was determined from 400 consecutive necropsy records and 200 consecutive medical inpatient episodes. Fatal pulmonary embolism was recorded in 29 of 400 necropsies; 17 were medical patients. Thirty one of 200 consecutive medical patients died. Fourteen necropsies were performed and revealed pulmonary embolism as the cause of death in five patients. The incidence of necropsy proven fatal pulmonary embolism was therefore 2.5% (95% confidence intervals 0.8% to 5.7%). Therefore, one in 40 medical patients had pulmonary embolism recorded as the cause of death at necropsy. As the necropsy rate was only 45% the incidence of fatal pulmonary embolism may be greater. There is, therefore, a need to perform more large prospective studies to confirm the incidence of fatal pulmonary embolism in medical patients and to identify risk factors and effective antithrombotic prophylaxis.
Similar articles
-
Fatal pulmonary embolism in hospitalised patients: a necropsy review.J Clin Pathol. 2004 Dec;57(12):1254-7. doi: 10.1136/jcp.2003.013581. J Clin Pathol. 2004. PMID: 15563663 Free PMC article.
-
The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation.J Bone Joint Surg Br. 1993 Nov;75(6):940-1. doi: 10.1302/0301-620X.75B6.8245087. J Bone Joint Surg Br. 1993. PMID: 8245087 Review.
-
Pulmonary embolism and mortality in patients with fractured hips--a prospective consecutive series.Eur J Surg. 1991 Oct;157(10):571-4. Eur J Surg. 1991. PMID: 1687245
-
Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.Lancet. 1975 Jul 12;2(7924):45-51. Lancet. 1975. PMID: 49649 Clinical Trial.
-
Prevention of fatal pulmonary embolism.Haemostasis. 1993 Mar;23 Suppl 1:42-50. doi: 10.1159/000216908. Haemostasis. 1993. PMID: 7684351 Review.
Cited by
-
Venous thromboembolism prophylaxis guideline compliance: a pilot study of augmented medication charts.Ir J Med Sci. 2015 Jun;184(2):469-74. doi: 10.1007/s11845-014-1148-6. Epub 2014 Jul 15. Ir J Med Sci. 2015. PMID: 25023126
-
Epidemiology and risk factors for venous thrombosis.Semin Hematol. 2007 Apr;44(2):62-9. doi: 10.1053/j.seminhematol.2007.02.004. Semin Hematol. 2007. PMID: 17433897 Free PMC article. Review.
-
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.BMJ. 2006 Feb 11;332(7537):325-9. doi: 10.1136/bmj.38733.466748.7C. Epub 2006 Jan 26. BMJ. 2006. PMID: 16439370 Free PMC article. Clinical Trial.
-
Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials.J Thromb Thrombolysis. 2015 Feb;39(2):222-7. doi: 10.1007/s11239-014-1145-7. J Thromb Thrombolysis. 2015. PMID: 25362508 Review.
-
Fatal pulmonary embolism in hospitalised patients: a necropsy review.J Clin Pathol. 2004 Dec;57(12):1254-7. doi: 10.1136/jcp.2003.013581. J Clin Pathol. 2004. PMID: 15563663 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials